PeriphaGen is a biopharmaceutical company focused on peripheral nerve gene therapy and committed to the development of innovative products for difficult-to-treat neurological disorders thereby improving patients' quality of life.

Pharmaceutical

PeriphaGen

PeriphaGen's headquarters in Pittsburgh, PA, United States

Peter Lanciano

David Fink

Guido Cavaletti

Axel Grothey

Charles Loprinzi

Patrick Douherty

Joanna Brell

James Albers

David Krisky

James Wechuck

Robert Dworkin

The Advisory Team at PeriphaGen provides strategic guidance and expert insights to drive the development of cutting-edge gene therapies for peripheral nerve and neurological disorders. Comprised of experienced advisors, they work collaboratively to optimize research, regulatory approval, and market strategies, ensuring innovative and effective solutions that enhance patients' quality of life.

Advisory Team

PeriphaGen

Org chart

Board & advisors

Teams

Advisory Team

Offices

PeriphaGen

Org chart

Board & advisors

Teams

Advisory Team

Offices

Related companies